PARP 捕获是由 PARP 抑制剂解离速率常数控制的
Angelica A Gopal1, Bianca Fernandez1, Justin Delano1
1Institute for Innovation in Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114; Center for Systems Biology, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114.
Cell chemical biology
|January 23, 2024
概括
聚 ((ADP-ribose) 聚合酶 (PARP) 抑制剂通过动力机制将PARP1捕获到DNA上,而不是物理停滞. 这种捕获效能与抑制剂的脱离率相关,澄清了癌症药物功能.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 聚 ((ADP-ribose) 聚合酶 (PARP) 抑制剂 (PARPi) 是重要的癌症治疗药物.
- PARPi通过抑制DNA损伤部位的PARP活性来起作用,主要是通过在DNA上捕获PARP1.
- 精确的PARP捕获机制和影响抑制剂功效的因素仍然不完全理解.
研究的目的:
- 为了阐明PARPi捕捉PARP1到DNA上的机制.
- 确定导致临床相关PARPi之间不同的捕获强度的因素.
- 为了澄清PARPi特性与它们的捕获效率之间的关系.
主要方法:
- 在DNA损伤部位使用动态分析研究PARP捕获.
- 与它们的解离动力学 (koff) 相关联的PARPi捕获功率.
- 研究了在PARP捕获的背景下DNA结合蛋白招募的作用.
主要成果:
- PARP捕获主要是发生在DNA损伤部位的动态现象.
- 捕获功效与抑制剂的脱离率 (koff) 有着强烈的相关性.
- 在没有竞争性蛋白质的情况下,PARP捕获不涉及物理停滞,而是有效地与受损DNA重新结合.
结论:
- 由PARPi捕捉PARP的机制被解释为一种动态过程.
- 帕尔皮的特性,特别是它们的解离率,直接影响它们的捕获力.
- 这些发现提供了对PARPi功能的更深入的理解,并指导开发更有效的癌症疗法.
相关概念视频
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Quantitative Aspects of Drug-Receptor Interaction
984
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower...
984
Long-patch Base Excision Repair
7.0K
Since the discovery of the two BER pathways, there has been a debate about how a cell chooses one pathway over the other and the factors determining this selection. Numerous in vitro experiments have pointed out multiple determinants for the sub-pathway selection. These are:
7.0K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
138
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
138


